Endoscopic management of obstructive pancreatitis with a metal stent in two family members with hereditary cationic trypsinogen (PRSS1) deficiency.

نویسندگان

  • Marine Camus
  • Sarah Leblanc
  • Dominique Debray
  • Ulriikka Chaput
  • Stanislas Chaussade
  • Frédéric Prat
چکیده

We report here the case of a 37-year-old woman and her daughter (now 12 years old) with genetically proven hereditary cationic trypsinogen (PRSS1) deficiency pancreatitis. The two patients were treated in a similar manner: endoscopic extraction of large obstructive stones located mainly in the head of the pancreas upstream of a stricture of the distal (cephalic) pancreatic duct and associated with extreme dilation (10–15mm) of the pancreatic duct, manifesting as bouts of mild acute pancreatitis and abdominal pain that could not relieved with analgesics (●" Fig.1–3). Both patients underwent pancreatic sphincterotomy, hydrostatic dilation of the pancreatic duct stricture with a 6-mm Hurricane RX Biliary Dilation Balloon (Boston Scientific, Natick, Massachusetts, USA), removal of the stone fragments with a Dormia basket, and placement of an 8-mm-diameter, 60-mm-long fully covered self-expandable metal stent (SEMS) (WallFlex Biliary RX Stent; Boston Scientific) to dilate the stricture and facilitate removal of the remaining stone fragments (●" Fig.4 and ●" Fig.5). The mother’s stent was left in place for 1 month and the daughter’s for 2 weeks. After stent removal, the mother experienced one episode of abdominal pain, with no further symptomatic relapse so far. Because of two flares of recurrent mild pancreatitis, the daughter underwent additional endoscopic therapeutic sessions; these consisted of a second stricture dilation, followed by placement of another fully covered SEMS for 3 months (same device) and subsequent placement of a 10-Fr plastic stent (Johlin Stent; Cook Medical, Winston-Salem, North Carolina, USA), which was withdrawn 3 months later. Since this procedure, the daughter has remained asymptomatic and has resumed school attendance uneventfully. Optimal stenting modalities have not been detailed in the rare reports devoted to patients with this condition [1–5]. The use of fully covered SEMS was of particular interest in these two patients, who presented with similar findings (short distal stricture and unusually large upstream dilation), because these stents can facilitate the removal of large stones and reduce the discrepancy between duct size in the head and body of the pancreas, a major factor in stone formation.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hereditary pancreatitis and mutation of the trypsinogen gene.

Hereditary pancreatitis is a rare form of chronic recurrent pancreatitis. A family, in which 11 members had chronic pancreatitis, five had diabetes, and two had pancreatic cancer, was studied, and hereditary pancreatitis was diagnosed in all patients by demonstrating the mutation in exon 3 of the cationic trypsinogen gene (R117H). The clinical implications of genotypic analysis in hereditary pa...

متن کامل

CLINICAL SCIENCES Lessons from Hereditary Pancreatitis

For decades there has been slow progress in understanding pancreatic diseases, particularly acute and chronic pancreatitis. As a result, there were no significant advances in the management of these patients. Treatment was mostly directed towards symptomatic relief and management of complications. A simple clinical observation that multiple members of a large family are affected by acute and ch...

متن کامل

Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism.

We investigated the biochemical properties and cellular expression of the c.346C>T (p.R116C) human cationic trypsinogen (PRSS1) mutant, which we identified in a German family with autosomal dominant hereditary pancreatitis. This mutation leads to an unpaired Cys residue with the potential to interfere with protein folding via incorrect disulfide bond formation. Recombinantly expressed p.R116C t...

متن کامل

Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis.

Hereditary pancreatitis (HP) is usually caused by mutations in the cationic trypsinogen (PRSS1) gene, especially R122H or N29I. We sequenced the PRSS1 gene in the proband of families without these common mutations. Novel R122C and N29T mutations were detected in independent families that segregated with the disease in an autosomal dominant fashion. The R122C mutation eliminates the arginine aut...

متن کامل

Trypsinogen gene mutations in patients with chronic or recurrent acute pancreatitis.

Three-point mutations (R117H, N211, A16V) within the cationic trypsinogen gene have been identified in patients with hereditary pancreatitis (HP). A genetic background has also been discussed for idiopathic juvenile chronic pancreatitis (IJCP), which closely mimicks the clinical pattern of HP, and alcoholic chronic pancreatitis because only a small number of heavy drinkers develop pancreatitis....

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Endoscopy

دوره 47 Suppl 1 UCTN  شماره 

صفحات  -

تاریخ انتشار 2015